• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchLite Strategy
    Picture of Lite Strategy logo

    LITS — Lite Strategy News Story

    $1.160.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      $35.27m
    • Enterprise Value
      $29.57m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • LITS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    LITS Dividends
    All News

    Brief: Mei Pharma Inc QTRLY Net Loss Per Share $0.40

    Picture of Lite Strategy logoLite Strategy
    12/02/2025 22:47
    MEI Pharma Inc  MEIP.O :
        * MEI PHARMA INC:  QTRLY NET LOSS PER SHARE $0.40
    
    Source text:  ID:n0000950170-25-018820 
    Further company coverage:  MEIP.O
    

    Recent news on Lite Strategy

    See all news
    • Brief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens

      18/06/2026 13:55
    • U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger

      15/01/2026 07:10
    • Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing

      18/11/2025 22:16
    • Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations

      17/11/2025 14:09
    • Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations

      29/10/2025 14:29

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.